Top Sector Life Sciences & Health (LSH) entails a broad scope of disciplines, from pharmaceuticals to medical technology and from healthcare infrastructure to vaccination. To realise its mission – vital citizens in a healthy economy - the Top Sector builds on the strengths of the Dutch LSH sector to address the biggest societal challenges in prevention, cure and care. By funding multidisciplinary public-private partnerships (PPPs) the Top Sector aims to facilitate innovation. Here we give an overview of  a number of funded R&D projects by Top Sector LSH. The page is updated continuously.

235 projects

  • Making engineered red blood cells safe for clinical use

    Development of a safe erythrocyte alternative composed of nanocoated oxygen-generating micromaterials
  • Bone-in-a-Box

    “Bone-in-a-Box” represents a humanised in vitro model of bone regeneration
  • Personalised Therapeutics @ LUMC

    PT@LUMC aims to improve our knowledge of (non-)genetic factors contributing to variability in drug response
  • Making functional beta-cells from stem cells in a dish

    Developing a new culture system to investigate the role of vascularization on pancreatic progenitor maturation
  • Immune-related proteins on tumors as target for imaging and therapy

    Immune-related proteins on tumor cells can be used for both, tumor visualization and therapy
  • Live imaging of cancer therapy responses in human breast cancer

    Improved anticancer drug discovery screens require mechanism-based phenotypic screens using human relevant tumor models
  • Improving immunotherapy of cancer by patient-specific vaccines

    Enhancing specific immunotherapy against cancer by adding adequate immunological help in DNA vaccines